Latest news articles

Added 4 days ago Drug news

Actelion Pharma withdraws filing of Opsumit for CTEPH

Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has announced its decision to voluntarily withdraw...

Added 11 days ago Drug news

Regeneron update on phase III progress in two trials of Libtayo to treat first line NSCLC.

Regeneron Pharmaceuticals, Inc. provided an update on the ongoing Phase III development program evaluating Libtayo (cemiplimab), a PD-1 inhibitor, as...

Added 13 days ago Drug news

Phase III results from two studies of Trikafta for cystic fibrosis published in The New England Journal of Medicine and The Lancet.- Vertex Pharma

Vertex Pharmaceuticals Incorporated announced the concurrent publication in The New England Journal of Medicine (NEJM) and The Lancet of results...

Search all news articles for Respiratory
 

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 7 more

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines.

Moderate to severe asthma

Moderate to severe asthma

Access the comprehensive Learning Zone for moderate to severe asthma. Containing details about pathophysiology, a complete overview of asthma and daily reports from ERS Congress 2019. 

Load more

 

Guidelines

ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.

These guidelines incorporate the recent advances in chronic cough pathophysiology, diagnosis and treatment. The concept of cough hypersensitivity has allowed an umbrella term that explains the exquisite sensitivity of patients to external stimuli

Added 1 month ago

Pneumonia in adults: diagnosis and management

This guideline covers diagnosing and managing community- and hospital-acquired pneumonia in adults.

Added 4 years ago

Tuberculosis

This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults.

Added 3 years ago

Search all guidelines for Respiratory
 

Journal articles

Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).

We describe 6 unrelated patients affected by infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) with prolonged survival upon mechanical ventilation (4.5 - 11 years), which has not been reported before.

Added 6 days ago

Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy.

Spinal muscular atrophy (SMA) is caused by insufficient levels of the survival motor neuron (SMN) protein leading to muscle paralysis and respiratory failure. In mouse, introducing the human SMN2 gene partially rescues Smn-/-...

Added 9 days ago

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.

Background: Previous studies have highlighted a relationship between reduction in rate of exacerbations with therapies containing inhaled corticosteroids (ICS) and baseline blood eosinophil count in patients with chronic...

Added 18 days ago

Search all journal articles for Respiratory
 

Clinical trials

Inhaled NAC in Treatment of IPF

This study plans to learn more about the safety and tolerability of inhaled N-Acetylcysteine (NAC) in patients with pulmonary fibrosis. The study will also create a bank of data, blood, and sputum from IPF patients for future research.

Added 27 days ago

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis (SMR3372)

Randomized, double blind, placebo controlled study. The study has two parts:
Dose-finding part, followed by longer term follow-up (6 months)

Added 1 month ago

Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) (ABRA)

Exacerbations of asthma and COPD are an important cause of hospital admission and the main cause of annual winter bed shortages. Despite current guideline treatment with prednisolone, 40% of patients require further treatment...

Added 1 month ago

Search all clinical trials for Respiratory
 

Blog Posts

Georgina Mason

ERS 2018 | Day 5 Highlights

Posted 1 year ago

The Asthma Report wraps up from Paris, with our final report from ERS Congress 2018.

 

Georgina Mason

ERS 2018 | Day 4 Highlights

Posted 1 year ago

A look at two sessions from the ERS Congress dealing with devices for the management of asthma and an in-depth look at some of the allergic responses to asthma.

Georgina Mason

ERS 2018 | Day 3 Highlights

Posted 1 year ago

Day 3 Highlights: Monday 17 September from the European Respiratory Society International Congress: 15-19 September 2018

CME

Managing acute exacerbations of COPD in primary care

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Chronic obstructive pulmonary disease: diagnosis and assessment of severity

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Older lady with uncontrolled COPD

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0
Search all CME for Respiratory